Kenneth Cunningham, Director at Verona Pharma plc (VRNA), sold 21,616 shares at $13.14 ($284K) on 2025-08-01, disclosed to the SEC on 2025-08-05.
Open-market sale of $284k VRNA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.14 | 10,808 | $142K | 50.0% |
| 2 | $13.14 | 10,808 | $142K | 50.0% |
| Total | $13.14 avg | 21,616 | $284K | 100% |
| Filing → |